Webinar: Breaking the Bottleneck: Implementation of a Middleware Solution for Automated Mass Spectrometry Data Review

"A significant bottle-neck for clinical mass spectrometry laboratories is the data review component. Auto-data review processes decrease these bottlenecks by providing major improvements in quality and patient safety while simultaneously decreasing time to review the mass spectrometry data.

In this webinar, Dr. Alec Saitman will provide insight into an auto-data review program developed by Providence Regional Laboratories. This program has unique advantage of providing dynamic rule flags against patient samples using calibrator averages of important data elements. By incorporating clinical mass spectrometry data review into middleware, we bridge the gap between mass spectrometry and automated instrumentation platforms."

Webinar: The Golden Age of the Clinical Lab-Dx: Transforming the Way Healthcare is Delivered

"The world of healthcare is changing – the clinical laboratory is changing with it. While the traditional, transactional lab model continues to serve as a foundation, the emerging clinical lab business model leverages longitudinal laboratory data to produce actionable, clinical insights that deliver better outcomes for patients, providers, and financial stakeholders alike. In this webinar, Khosrow R. Shotorbani, MBA MT (ASCP), Founder & CEO, Lab 2.0 Strategic Services, LLCC, will teach you how to re-engineer the role of the lab in the care continuum, aligning it with the future of value-based healthcare."

Webinar: Managing Change in the Lab – The People Side of Data Management Innovation

"When a 24/7 hospital laboratory introduces new workflow and result management software, challenges can arise, especially when trying to minimize operational disruptions. People play a critical role in change management and project success when integrating new technology.

Join Susan Dawson, Lab Director of Swedish Covenant Hospital in Chicago, as she describes pain points labs should avoid when integrating new technologies and shares best practices she’s learned while managing innovation-based change in a data-driven multidisciplinary laboratory with a long history of continuous improvement."

Webinar: Understanding and Overcoming the Challenges of Manual Inventory Management

"Error-prone and inefficient manual inventory methods can disrupt workflows, burden techs, and strain a laboratory's operating budget. When you look closely at the many costs associated with manual inventory tracking, you see they are many times the cause of these challenges.

Join Stephen Gombos, Lab Manager at Licking Memorial Hospital, as he discusses his journey to investigate and overcome the manual inventory challenges he faced at his Newark, Ohio laboratory."

Webinar: What Labs Can Do to Address the Opioid Crisis

"Today’s laboratories can play a key role in addressing the opioid crisis. Join Prentiss Jones, PhD as he shares his insights on implications of the opioid epidemic in the U.S. and what laboratories can do to address this crisis."

Webinar: Curbing the Opioid Crisis: The Role of the Clinical Laboratory for Pain Management

"On average, 130 Americans die every day from an overdose of opioids, the class of drugs that includes heroin, hydrocodone, codeine, morphine and fentanyl. Drug overdose is now the leading cause of accidental death in the United States. In this webinar, you will learn why your clinical laboratory is critically important in helping clinicians care for patients struggling with drug abuse. You will also learn about the advantages of using a specific urine drug screening technology that eliminates cross-reactivities with other drugs. Additionally, advantages of using oral fluid samples will be presented."

Webinar: Cytokine Storm Syndrome & COVID-19

"Cytokine storm syndrome (CSS) in an umbrella term for a potentially fatal immune response associated with a variety of conditions and triggers. It is known by many names, including macrophage activation syndrome (MAS) when associated with rheumatic diseases, or familial hemophagocytic lymphohistiocytosis (HLH) as a genetic condition that most often affect infants. Many common forms of CSS are often triggered by infections, particularly viruses, of which Covid-19 appears to be included. In this webinar, Dr. Randy Cron will discuss criteria for identifying CSS in patients, complications, and available treatments which include glucocorticoids, but also targeted therapies that dampen pro-inflammatory cytokines like interleukin-1 (IL-1) and IL-6."

Webinar: Analytics in the Clinical Laboratory with R: An Expert Panel

"R is a freely available, open-source programming language and a powerful statistical computing environment that is popular among statisticians and data scientists. R is ideally suited for building analytics pipelines and customized applications for clinical operations; however, real and perceived hurdles exist in operationalizing R in the clinical lab and healthcare as a whole.

This panel discussion is carried out in collaboration between AACC and the organizers of R/Medicine, an annual conference that aims to promote the R ecosystem in clinical research and practice. The panelists are Laboratory Directors, who will discuss how they successfully implemented analytics solutions using R at their institutions."

Webinar: Current State of COVID-19 Point-of-Care Testing: Blood Gases, Biomarkers, and Future Directions

"The majority of COVID-19 testing has focused on molecular, antigen, and serology-based assays. Other routine tests also play a critical role in diagnosing and managing COVID-19. Dr. Nam K. Tran will provide an overview of common chemistry and point-of-care tests employed when treating COVID-19 patients. These include blood gas analysis and biomarkers of infection and injury. He will also discuss future directions such as the use of machine learning and mass spectrophotometric methods now under investigation."

Webinar: SARS-CoV-2 Testing: Selecting the Right Test for the Right Person

"Implementing the correct test at the appropriate time is crucial for SARS-CoV-2 diagnosis, public health surveillance, and limiting the spread of the virus. However, the frequent emergence of new assays, changes to regulations, and constantly revising guidelines may cause considerable confusion among laboratorians. This webinar will provide an overview of the diagnostic and serologic methods for SARS-CoV-2, their clinical utility, and how to effectively navigate the guidelines and regulations to implement appropriate SARS-CoV-2 testing."

Webinar: On the Horizon of SARS-CoV-2 Testing: Improving Testing, Technologies, and Collaborations Across the Healthcare Team

"How are we staying ahead of the coronavirus? As the world looks ahead, Drs. Luning and Wang will discuss the information that is or will be available to help the laboratory medicine and broader healthcare community that will help combat the unique challenges of SARS-CoV-2 spread and testing. Learn about novel solutions and emerging technologies in SARS-CoV-2 testing. As the testing techniques are improving, you will need to learn how to improve communications with the broader healthcare team to coordinate testing and ultimately patient care."

Webinar: SARS-CoV-2 2021: A Panel Discussion on Impact of SARS-CoV-2 and Near-Future Considerations

"As we approach the end of year, we need to look forward. The unique challenges of SARS-CoV-2 and SARS-CoV-2 testing this past year will provide some insight into what we need to think about going into a new year. What will we expect after this influenza season and what impact will that have for the population and vaccine development? The panelist will share their unique insights and what key role we all serve in the fight going forward."

Webinar: The Need for Speed: Strategies to assess the right QC for SARS-CoV-2 and Infectious Diseases Assays

"Learn how to solve your most challenging SARS-CoV-2 quality control issues in this live webinar with expert Nathan Ledeboer, PhD. He will discuss the roles and benefits of 3rd party quality controls and explain how to identify control material, assayed QC versus non-assayed QC, and how to use QC middleware systems to achieve your lab goals. A live Q&A will follow the presentation."

AACC Annual Scientific Meeting & Clinical Lab Expo

McCormick Place 2301 S King Dr., Chicago, IL

Annual meeting of the American Association for Clinical Chemistry, plus clinical laboratory trade show Note: Rescheduled from July 26–30 due to COVID-19

Webinar: Thermal Cameras and FDA Guidelines: Fact vs. Fiction in Protecting Your Hospitals and Clinical Laboratories

"Thermal cameras are everywhere it seems, yet many lab directors and lab managers wonder if the latest generation is a cure-all for protecting hospitals and clinical laboratories... or a risk to public health.

Not to worry, the Food & Drug Administration (FDA) recently helped clarify fact from fiction with their recent F510(K) clearance guidelines.

Join AACC and Peter Baird to learn how the FDA's 510(K) clearance applies to clinical laboratories and academic environments to best protect your staff and patients. Plus, learn the risk associated with cheap imports without FDA 510(K) clearance and how they have led the market to uncertainty. This is an important discussion for anyone evaluating the risk and reward of new technology, such as thermal imaging.

This is an important discussion for anyone evaluating the risk and reward of integrating a new technology such as thermal imaging in their lab, hospital, or academic environment."

Webinar: Peripheral Blood Smears: A Novel Full Field Morphology Approach to Closing the Gap Between Manual and Digital Workflows

"Do you dare to imagine an all-digital workflow for blood smears review? If your answer is "yes", join Dr. Olga Pozdnyakova for an introduction to the novel full-field digital technology and its comparison to the current state of manual and digital technologies for microscopy applications. Dr. Pozdnyakova will present the results of a multi-institutional FDA clinical trial, including representative full field peripheral blood smear (FFM-PBS) cans, simulating comprehensive morphological analysis of real-life blood smears, and the clinical benefits of this innovative approach.

Full field digital cell morphology represents true progress in standardization, efficiency, remote workflow capability, and scalability of hematological examination. It fundamentally changes laboratory practice and closes the gap between the manual and digital microscopic PBS review."

Webinar: SARS-COV-2 Variants: What to Detect and How to Do It

"The science on and surrounding SARS-COV-2 and the application of laboratory medicine towards combating the pandemic has evolved at a blistering, unprecedented pace. The majority of the first year of the pandemic focused on the development and deployment of multiple test modalities for the detection of SARS-COV-2, from PCR to Antigen, as the world as a whole strived to develop a vaccine in record time. Now as we enter the second year of the SARS-COV-2 pandemic, focus shifts to understanding our new vaccine-induced immunity and the continued development and spread of SARS-COV-2 variants. Major issues faced by laboratory medicine include the role of serology testing in a vaccinated population with the goal of identifying a true correlate of immunity, and the possible effects of variants on viral detection methods. The designated roles of public health and clinical laboratories as well as the lines between surveillance, screening, and diagnostic testing continues to blur for many health systems. This webinar strives to provide attendees with a condensed yet comprehensive understanding on these two issues from experts in the field facing these challenges on a daily basis. Because information and developments on SARS-COV-2 is so fragmented even in the scientific landscape, this webinar assists in amalgamating current knowledge on the current and upcoming use of serology and variant testing in the SARS-COV-2 pandemic."

Webinar: Standardization of COVID-19 Serological Assays: Establishment of the WHO International Standard and its Importance

"Since the beginning of the pandemic, hundreds of serological tests have been developed, including more than 80 tests that received U.S. Food and Drug Administration Emergency Use Authorization. These tests represent different formats and have different viral antigen targets. The tests also detect different antibody isotypes and report qualitative or semi-quantitative or quantitative test results. Hundreds of studies have been published using multiple antibody assays, however, it is challenging to compare results or aggregate data since the assays were not calibrated to an international standard.

To address this challenge, the World Health Organization (WHO) generated an International Standard for SARS-CoV-2 antibodies. This webinar will provide attendees with an overview of how this standard was developed, how it supports serological assay development, and its role in the pandemic. The calibration of serological assays to a common unitage will improve our understanding of the virus epidemiology, and vaccine and therapeutic efficacies."

Webinar: Point of Care Testing in the Emergency Department: Challenges, Opportunities and Vision for the Future

"Point-of-care testing (POCT) enables rapid clinical decision-making in the process of diagnosis, treatment choice and monitoring, prognosis, as well as operational decision making. Emergency Departments (ED) are often overcrowded so the role of POCT can help improve efficiencies allowing emergency departments to address the overcrowding. Discover common tests performed at the point of care (POC) in the Emergency Department, as well as evidence supporting improved patient outcomes or hospital efficiency thru use of POC in the ED. During a panel discussion, between a point of care medical director and two emergency medicine physicians, the most useful panels or groups of tests for rapid decision-making in the ED will be discussed. Learn about over-utilization of POC in the ED, and pitfalls and challenges associated with the use and interpretation of POC tests in this environment."

Webinar: The Pressing Need for Data Analytics Literacy in Laboratory Medicine

"As the clinical laboratory generates much of the data used to diagnose, treat, and manage patients, there are many contexts in which data can be applied to improve the operation of the laboratory, the quality and accuracy of laboratory results, and patient care overall. Despite working in an environment with rich opportunities to apply data, many training programs have not provided formal training in data analytics. This webinar provides an introduction to data analytics concepts and how laboratorians can further develop their roles and skills in data analysis."

Webinar: The Five Ws (Why, Who, What, Where, When) of Reimbursement and Regulation for Diagnostics

"It is critical for any U.S. lab performing clinical diagnostics to thoroughly understand the “ins and out” of the current US Regulatory & Reimbursement systems. Laboratorians and future laboratorians will learn about the latest changes in these processes. This information is instrumental to labs performing EUA tests today to learn what will change when the COVID-19 pandemic ends, or another health emergency occurs. The webinar will also describe the choices that an individual lab or IVD manufacturer has in securing approvals to market their product(s) in the United States."

Webinar: Best Practices for Optimizing Laboratory Resources and Utilization During a Global Supply Shortage

"One direct result of the global pandemic that has impacted the lab is a supply shortage to manufacture specimen collection tubes. Due to limited supplies, laboratory professionals and healthcare institutions must review lab utilization and mitigating resource waste. Many factors may need to be considered from ordering practices to test ordering procedures. Listen to our panel of faculty to hear best practices and recommendations to overcome these challenges to mitigate distribution to your daily practice."

Webinar: Establishing QC Targets and Ranges for Multiple Instruments

"Laboratories with more than one identical instrument need to be able to calculate and understand their actual laboratory performance, because the physician and patient are interested in the quality of the results irrespective of which instrument performed the test. Based on this overall performance it is important to design a quality control (QC) strategy across these instruments. This webinar will describe the difference between the traditional instrument focused assessments and a patient focused assessment. It will also provide guidance on how to establish the QC targets and QC ranges when using multiple instruments."

Webinar: The Next Evolution of Molecular Testing Post COVID-19

"As COVID-19 changes from pandemic to endemic, laboratories will likely face challenges in the rapid shift in testing capacity needs. In particular, laboratories will have invested in infrastructure, testing platforms, and highly skilled personnel, which can now be leveraged for other molecular testing needs with appropriate planning. Adapting to these changes are crucial to making the best use of excess testing capacities in a post-COVID-19 lab environment.

This webinar will focus on how clinical laboratories can assess their current molecular testing capabilities and how excess capacity can be adapted to meet other molecular testing, including infectious disease testing. Moreover, the webinar will provide market insights, testing trends, and details on how laboratories can create an implementation plan to continue to evolve their business."

Webinar: Measurement Uncertainty, From Theory to Practice

"Calculation of Measurement Uncertainty (MU) is an accreditation requirement for many medical laboratories worldwide. The requirement is derived from ISO 15189:2012, subclause 5.5.1.4, and now applies to any lab accredited to ISO 15189. MU characterizes the dispersion of the quantity values being attributed to a measurand, but for a long time laboratories continued to include different contributions of uncertainty in their calculations. In 2019, a new guidance document was published: ISO/TS 20914, “Medical laboratories—Practical guidance for the estimation of measurement uncertainty”. This webinar will provide an overview of how to calculate and apply MU in the medical laboratory for quality assurance and interpretation of patient results."

Webinar: Know Thy Lab Neighbor: Opportunities in Clinical Microbiology to Interface with Other Laboratory Disciplines

Collaborative approaches can help develop the quality and efficiency of the clinical microbiology laboratory with the goal of improving patient outcomes. The webinar will utilize real world examples to demonstrate collaborative strategies. It will also discuss how to capture data on impact of these efforts and the importance of this approach in demonstrating the value of the laboratory.

Webinar: Data Science Applications in Laboratory Medicine

"The practice of medicine is changing rapidly to include the introduction of automated and algorithmic solutions to clinical and operational challenges. These approaches represent a dramatic improvement over manual paper-based healthcare practices.

In this webinar, Dr. Daniel Holmes will provide examples of data analytics applications in laboratory medicine to demonstrate how laboratory data can be leveraged to improve healthcare delivery and operations. Exploration of data analytic tools, including select applications of machine learning, will be covered to illustrate how they can be utilized to automate manual laboratory processes, develop new quality monitoring and assurance tools, and support clinical/operational decisions. Dr. Holmes will demonstrate how the analysis of laboratory data yields information that is necessary for the evidence-based planning and decision making in the health care system."

Webinar: Setting Yourself Up for Data Analytics Success

"This webinar will discuss the required infrastructure needed to successfully implement data analytics for laboratory medicine applications. How is data typically stored and accessed in a healthcare environment? How does the LIS fit into the larger infrastructure of health information technology? How do you build the awareness of the local environment, access to data, and resources that you need to perform analytics? What skillsets and technology resources are needed?

Drs. Mathias, and Obstfeld will provide their perspectives on key concepts for successfully implementing data analytics for laboratory medicine. These presentations will be followed by an open panel discussion moderated by Dr. Haymond."

Webinar: Enough Is Enough: How Much Revalidation Do I Really Need to Do?

"Understanding the requirements for revalidation of molecular microbiology testing instrumentation can be challenging for laboratory leaders. Regulatory agencies such as CAP and CLIA often require revalidation but provide minimal guidance on what additional testing is required prior to putting instruments back into clinical use. Further, practical and actionable guidance on when and how to revalidate testing instruments is largely unavailable.

This webinar will provide an overview of the CAP/CLIA check list items relevant to revalidation of molecular microbiology testing instruments. It will also address when and how revalidations of instruments should be performed. Finally, using a case-based approach, it will discuss general best practices associated with revalidation of laboratory instruments, including to what extent (e.g., sample types, sample size, etc.) testing is needed for commonly encountered scenarios."

Webinar: Exploring MolDX and Payer Guidelines for Molecular Testing

"Labs performing molecular infectious disease testing within a MolDX jurisdiction must now register for a unique DEX code z-identifier to receive a fixed reimbursement for laboratory developed tests or “expanded” panels that test for more than five targets. During this webinar we will review the MolDX program, and under which conditions the labs need to apply for a new Z-code.

At the end of the webinar the attendees will have an understanding of the reimbursement landscape for molecular testing and how the new MolDX requirements should be applied in daily routine."